Pharmaceuticals Portfolio
Name
As of 04/15/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
12.6%
1 yr return
21.6%
3 Yr Avg Return
11.7%
5 Yr Avg Return
14.8%
Net Assets
$1.08 B
Holdings in Top 10
72.5%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 0.70%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover 29.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$0
IRA
N/A
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 04/15/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
FPHAX - Profile
Distributions
- YTD Total Return 12.6%
- 3 Yr Annualized Total Return 11.7%
- 5 Yr Annualized Total Return 14.8%
- Capital Gain Distribution Frequency Semi-Annually
- Net Income Ratio 1.10%
- Dividend Yield 1.1%
- Dividend Distribution Frequency None
Fund Details
-
Legal NamePharmaceuticals Portfolio
-
Fund Family NameFidelity Investments
-
Inception DateJul 11, 2001
-
Shares OutstandingN/A
-
Share ClassOther
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerKarim Suwwan de Felipe
Fund Description
FPHAX - Performance
Return Ranking - Trailing
Period | FPHAX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 12.6% | -26.5% | 12.6% | 0.61% |
1 Yr | 21.6% | -27.9% | 21.6% | 0.61% |
3 Yr | 11.7%* | -35.1% | 11.7% | 0.64% |
5 Yr | 14.8%* | -6.8% | 14.8% | 0.73% |
10 Yr | 10.1%* | 0.3% | 13.8% | 28.04% |
* Annualized
Return Ranking - Calendar
Period | FPHAX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | 3.6% | -12.6% | 19.0% | 38.65% |
2022 | -4.0% | -53.9% | 3.2% | 9.62% |
2021 | 0.2% | -39.6% | 24.2% | 51.92% |
2020 | 1.6% | -13.6% | 178.2% | 90.73% |
2019 | 21.0% | 3.8% | 63.8% | 50.37% |
Total Return Ranking - Trailing
Period | FPHAX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 12.6% | -26.5% | 12.6% | 0.61% |
1 Yr | 21.6% | -27.9% | 21.6% | 0.61% |
3 Yr | 11.7%* | -35.1% | 11.7% | 0.64% |
5 Yr | 14.8%* | -6.8% | 14.8% | 0.73% |
10 Yr | 10.1%* | 0.3% | 13.8% | 28.04% |
* Annualized
Total Return Ranking - Calendar
Period | FPHAX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | 12.5% | -12.6% | 19.0% | 9.20% |
2022 | 1.0% | -53.9% | 3.7% | 4.49% |
2021 | 11.8% | -33.9% | 26.0% | 34.62% |
2020 | 11.1% | -0.7% | 180.6% | 91.39% |
2019 | 31.6% | 4.6% | 63.8% | 25.93% |
NAV & Total Return History
FPHAX - Holdings
Concentration Analysis
FPHAX | Category Low | Category High | FPHAX % Rank | |
---|---|---|---|---|
Net Assets | 1.08 B | 7.41 M | 47.2 B | 44.17% |
Number of Holdings | 67 | 23 | 413 | 65.64% |
Net Assets in Top 10 | 594 M | 2.19 M | 20.5 B | 35.58% |
Weighting of Top 10 | 72.53% | 18.1% | 77.0% | 3.07% |
Top 10 Holdings
- ELI LILLY and CO 24.06%
- NOVO-NORDISK AS CL B ADR 14.76%
- ASTRAZENECA PLC SPONS ADR 9.35%
- MERCK and CO INC NEW 4.96%
- GSK PLC SPONS ADR 4.95%
- GILEAD SCIENCES INC 3.27%
- UCB SA 3.08%
- ROYALTY PHARMA PLC 3.01%
- MERCK KGAA 2.76%
- ROCHE HOLDINGS AG (GENUSSCHEINE) 2.32%
Asset Allocation
Weighting | Return Low | Return High | FPHAX % Rank | |
---|---|---|---|---|
Stocks | 98.79% | 87.17% | 106.13% | 33.13% |
Cash | 1.05% | 0.00% | 32.99% | 63.19% |
Preferred Stocks | 0.74% | 0.00% | 7.86% | 23.93% |
Bonds | 0.11% | 0.00% | 12.39% | 8.59% |
Other | 0.00% | -22.99% | 17.73% | 55.83% |
Convertible Bonds | 0.00% | 0.00% | 0.37% | 42.41% |
Stock Sector Breakdown
Weighting | Return Low | Return High | FPHAX % Rank | |
---|---|---|---|---|
Healthcare | 100.00% | 59.26% | 100.00% | 19.62% |
Utilities | 0.00% | 0.00% | 0.00% | 37.97% |
Technology | 0.00% | 0.00% | 22.69% | 43.67% |
Real Estate | 0.00% | 0.00% | 5.89% | 40.51% |
Industrials | 0.00% | 0.00% | 7.02% | 42.41% |
Financial Services | 0.00% | 0.00% | 1.60% | 56.33% |
Energy | 0.00% | 0.00% | 0.00% | 37.97% |
Communication Services | 0.00% | 0.00% | 9.11% | 41.14% |
Consumer Defense | 0.00% | 0.00% | 25.73% | 46.20% |
Consumer Cyclical | 0.00% | 0.00% | 1.92% | 41.14% |
Basic Materials | 0.00% | 0.00% | 7.16% | 58.86% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | FPHAX % Rank | |
---|---|---|---|---|
US | 87.72% | 66.21% | 104.41% | 65.64% |
Non US | 11.07% | 0.00% | 28.58% | 28.83% |
Bond Sector Breakdown
Weighting | Return Low | Return High | FPHAX % Rank | |
---|---|---|---|---|
Cash & Equivalents | 1.05% | 0.00% | 100.00% | 55.83% |
Derivative | 0.00% | -0.03% | 17.73% | 47.85% |
Securitized | 0.00% | 0.00% | 0.00% | 38.03% |
Corporate | 0.00% | 0.00% | 83.51% | 48.59% |
Municipal | 0.00% | 0.00% | 1.73% | 38.73% |
Government | 0.00% | 0.00% | 29.44% | 39.44% |
Bond Geographic Breakdown
Weighting | Return Low | Return High | FPHAX % Rank | |
---|---|---|---|---|
US | 0.11% | 0.00% | 11.75% | 8.59% |
Non US | 0.00% | 0.00% | 3.33% | 38.65% |
FPHAX - Expenses
Operational Fees
FPHAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 0.70% | 0.08% | 4.28% | 75.46% |
Management Fee | 0.69% | 0.03% | 1.25% | 52.15% |
12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
FPHAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | N/A | 3.50% | 5.75% | N/A |
Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
FPHAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 1.00% | 70.73% |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
FPHAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 29.00% | 0.00% | 238.00% | 21.01% |
FPHAX - Distributions
Dividend Yield Analysis
FPHAX | Category Low | Category High | FPHAX % Rank | |
---|---|---|---|---|
Dividend Yield | 1.12% | 0.00% | 6.35% | 10.43% |
Dividend Distribution Analysis
FPHAX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | None | Annual | Annual | Annual |
Net Income Ratio Analysis
FPHAX | Category Low | Category High | FPHAX % Rank | |
---|---|---|---|---|
Net Income Ratio | 1.10% | -2.54% | 1.85% | 5.77% |
Capital Gain Distribution Analysis
FPHAX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Semi-Annually | Annually | Semi-Annually | Annually |
Distributions History
Date | Amount | Type |
---|---|---|
Dec 22, 2023 | $0.872 | OrdinaryDividend |
Dec 19, 2022 | $0.925 | OrdinaryDividend |
Apr 10, 2017 | $0.023 | OrdinaryDividend |
Dec 19, 2016 | $0.183 | OrdinaryDividend |
Apr 16, 2012 | $0.045 | OrdinaryDividend |
Dec 12, 2011 | $0.077 | OrdinaryDividend |
Apr 07, 2011 | $0.035 | OrdinaryDividend |
Dec 13, 2010 | $0.110 | OrdinaryDividend |
Apr 12, 2010 | $0.020 | OrdinaryDividend |
Dec 14, 2009 | $0.115 | OrdinaryDividend |
Apr 20, 2009 | $0.040 | OrdinaryDividend |
Dec 15, 2008 | $0.110 | OrdinaryDividend |
Apr 14, 2008 | $0.020 | OrdinaryDividend |
Dec 17, 2007 | $0.070 | OrdinaryDividend |
Apr 16, 2007 | $0.040 | OrdinaryDividend |
Dec 18, 2006 | $0.030 | OrdinaryDividend |
Apr 10, 2006 | $0.010 | OrdinaryDividend |
Dec 19, 2005 | $0.010 | OrdinaryDividend |
Apr 11, 2005 | $0.005 | OrdinaryDividend |
FPHAX - Fund Manager Analysis
Managers
Karim Suwwan de Felipe
Start Date
Tenure
Tenure Rank
Jul 01, 2017
4.92
4.9%
Karim Suwwan de Felipe is portfolio manager of Pharmaceuticals Portfolio, which he has managed since July 2017. Since joining Fidelity Investments in 2010, Mr. Suwwan de Felipe has worked as a research analyst and portfolio manager
Tenure Analysis
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.02 | 24.72 | 7.84 | 0.25 |